Details for New Drug Application (NDA): 020014
✉ Email this page to a colleague
The generic ingredient in MAXAIR is pirbuterol acetate. There are three drug master file entries for this compound. Additional details are available on the pirbuterol acetate profile page.
Summary for 020014
Tradename: | MAXAIR |
Applicant: | Bausch |
Ingredient: | pirbuterol acetate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | AEROSOL, METERED;INHALATION | Strength | EQ 0.2MG BASE/INH | ||||
Approval Date: | Nov 30, 1992 | TE: | RLD: | No |
Expired US Patents for NDA 020014
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Bausch | MAXAIR | pirbuterol acetate | AEROSOL, METERED;INHALATION | 020014-001 | Nov 30, 1992 | 4,664,107 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription